Home LiteratureArticle Details
PMID: 3343376 Published · ppublish English Journal Article

Retrospective study of prognostic importance of DNA flow cytometry of urinary bladder carcinoma.

Journal of clinical pathology ·Vol. 41 ·No. 1 ·1988-01-00 ·Pages 21-5

Blomjous CE, Schipper NW, Baak JP, van Galen EM, de Voogt HJ, Meyer CJ

Abstract

Cellular DNA content was determined by flow cytometry on routinely processed paraffin sections of 61 primary and untreated transitional cell carcinomas of the urinary bladder, and correlated with tumour grade and stage and clinical follow up. All 16 (25%) grade 1 carcinomas were diploid and all 11 (20%) grade 3 tumours were aneuploid. The 34 (55%) grade 2 carcinomas comprised 13 (40%) diploid and 21 (60%) aneuploid cases. Among the 37 superficial carcinomas (stage Ta and T1), 25 (65%) were diploid; 20 (85%) of the 24 advanced tumours (stage T2 to T4) had aneuploid tracings. Ploidy was a significant prognostic indicator (p: 0.006) of five year survival. The initial presence of aneuploidy in superficial bladder carcinoma (stage Ta and T1) is a strong argument for more aggressive treatment than is customary.

MeSH Terms
Aged Aged, 80 and over Carcinoma, Transitional Cell/analysis DNA, Neoplasm/analysis Female Flow Cytometry Humans Male Middle Aged Neoplasm Staging Prognosis Recurrence Retrospective Studies Urinary Bladder Neoplasms/analysis,pathology
Chemicals
DNA, Neoplasm
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Blomjous C E
Department of Pathology, Free University Hospital, Amsterdam, The Netherlands.
Schipper N W
Baak J P
van Galen E M
de Voogt H J
Meyer C J
References (25)
25 references, click to expand
  1. Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years.
    Acta Chir Scand. 1965 Oct;130(4):371-8 PMID: 5842510
  2. Tumors of the urinary bladder: a clinico-pathological analysis of over 2500 specimens and biopsies.
    J Urol. 1955 Oct;74(4):498-521 PMID: 13264313
  3. Chromosomes in noninvasive papillary carcinoma of the bladder.
    JAMA. 1971 May 3;216(5):791-4 PMID: 5108284
  4. Chromosome constitution of transitional cell carcinoma of the urinary bladder.
    Cancer. 1972 May;29(5):1401-12 PMID: 4623254
  5. [Cytophotometric studies of transitional epithelial bladder tumors. Comparison of cytophotometric results with histological grading].
    Beitr Pathol. 1972;147(4):379-89 PMID: 4649098
  6. Antigenic deletion and prognosis of patients with stage A transitional cell bladder carcinoma.
    J Urol. 1975 Dec;114(6):874-8 PMID: 1195466
  7. Cell locomation and tumor penetration. Report on a workshop of the EORTC cell surface project group.
    Eur J Cancer. 1977 Jan;13(1):1-12 PMID: 557410
  8. Changes in grade and stage of recurrent bladder tumors.
    J Urol. 1977 Jul;118(1 Pt 2):177-8 PMID: 875215
  9. Luminal plasma membrane alterations in bladder cancer.
    Invest Urol. 1980 Mar;17(5):364-72 PMID: 6987189
  10. Bladder cancer diagnosis by flow cytometry. Correlation between cell samples from biopsy and bladder irrigation fluid.
    Cancer. 1980 May 1;45(9):2389-94 PMID: 6155204
  11. DNA profile and tumour progression in patients with superficial bladder tumours.
    Urol Res. 1982 Feb;10(1):13-8 PMID: 7072022
  12. The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumours: a study of 100 untreated cases.
    Br J Urol. 1982 Apr;54(2):130-5 PMID: 7082931
  13. Blood group precursor T-antigen expression in human urinary bladder carcinoma.
    Am J Clin Pathol. 1982 Jun;77(6):692-9 PMID: 7091049
  14. Mode of presentation of invasive bladder cancer: reassessment of the problem.
    J Urol. 1982 Jul;128(1):31-3 PMID: 7109064
  15. Immunoperoxidase detection of carcinoembryonic antigen and blood group substances in papillary transitional cell carcinoma of the bladder.
    J Urol. 1982 Aug;128(2):276-80 PMID: 7050419
  16. Analysis of the performance of pathologists in the grading of bladder tumors.
    Hum Pathol. 1983 Feb;14(2):140-3 PMID: 6832758
  17. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.
    J Histochem Cytochem. 1983 Nov;31(11):1333-5 PMID: 6619538
  18. Efficacy of prolonged intermittent therapy with combined 5-fluorouracil and methyl-CCNU following resection for carcinoma of the large bowel. A Veterans Administration Surgical Oncology Group report.
    Cancer. 1984 Jan 1;53(1):1-8 PMID: 6360325
  19. ABO(H) isoantigens in bladder tumors: a new technique of quantitative analysis.
    J Urol. 1984 Feb;131(2):245-8 PMID: 6699953
  20. Relation between flow cytometric DNA distribution and pathology in human bladder cancer. A report on 69 cases.
    Cancer. 1984 Nov 1;54(9):1771-7 PMID: 6478413
  21. Deoxyribonucleic acid analysis in the evaluation of transitional cell carcinoma before cystectomy.
    J Urol. 1984 Nov;132(5):894-8 PMID: 6492278
  22. Flow cytometric analysis of DNA content in human bladder tumors and irrigation fluids.
    Cancer. 1985 Oct 1;56(7):1677-81 PMID: 4027899
  23. Characterization of bladder carcinomas by flow DNA analysis.
    Eur Urol. 1985;11(6):410-7 PMID: 4085533
  24. A, B, H antigen expression in transitional cell carcinomas of the urinary bladder.
    Cancer. 1986 May 1;57(9):1768-75 PMID: 2420436
  25. Correlation of chromosome counts with histological appearances and prognosis in transitional-cell carcinoma of bladder.
    Br Med J. 1967 Feb 4;1(5535):273-7 PMID: 6017478
Article Info
Journal
Journal of clinical pathology
Abbr.
J Clin Pathol
ISSN
0021-9746
Published
1988-01-00
Pages
21-5
Language
English
Region
England
NLM ID
0376601
PMCID
PMC1141329
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]